Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
TAB İlaç is a Turkish pharmaceutical company established in 2011, headquartered in Istanbul. The company specializes in the development, production, and marketing of pharmaceuticals and high-quality food supplements. Their product portfolio is notably strong in the magnesium and vitamin segments, featuring well-known brands such as Magnorm and Osende. TAB İlaç operates its own state-of-the-art manufacturing facility that adheres to Good Manufacturing Practices (GMP) standards. The company focuses on providing innovative health solutions to the Turkish market and is expanding its reach through international exports. Their research and development efforts are centered on creating effective formulations for nutritional deficiencies and general wellness.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on TAB İlaç.